Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Short Bowel Syndrome Drugs market report explains the definition, types, applications, major countries, and major players of the Short Bowel Syndrome Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Nutrinia
Sancilio Pharmaceuticals
Naia Pharmaceuticals
Takeda
Ardelyx
Merck
OxThera
Zealand Pharma
Emmaus Medical
By Type:
Glucagon-Like Peptide-2 (GLP-2)
Growth Hormone
Glutamine
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Short Bowel Syndrome Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Short Bowel Syndrome Drugs Outlook to 2028- Original Forecasts
-
2.2 Short Bowel Syndrome Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Short Bowel Syndrome Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Short Bowel Syndrome Drugs Market- Recent Developments
-
6.1 Short Bowel Syndrome Drugs Market News and Developments
-
6.2 Short Bowel Syndrome Drugs Market Deals Landscape
7 Short Bowel Syndrome Drugs Raw Materials and Cost Structure Analysis
-
7.1 Short Bowel Syndrome Drugs Key Raw Materials
-
7.2 Short Bowel Syndrome Drugs Price Trend of Key Raw Materials
-
7.3 Short Bowel Syndrome Drugs Key Suppliers of Raw Materials
-
7.4 Short Bowel Syndrome Drugs Market Concentration Rate of Raw Materials
-
7.5 Short Bowel Syndrome Drugs Cost Structure Analysis
-
7.5.1 Short Bowel Syndrome Drugs Raw Materials Analysis
-
7.5.2 Short Bowel Syndrome Drugs Labor Cost Analysis
-
7.5.3 Short Bowel Syndrome Drugs Manufacturing Expenses Analysis
8 Global Short Bowel Syndrome Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Short Bowel Syndrome Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Short Bowel Syndrome Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Short Bowel Syndrome Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Short Bowel Syndrome Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Glucagon-Like Peptide-2 (GLP-2) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Glutamine Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Short Bowel Syndrome Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Online Pharmacies Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Short Bowel Syndrome Drugs Market Analysis and Outlook till 2022
-
10.1 Global Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.2.2 Canada Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.2.3 Mexico Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.2 UK Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.3 Spain Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.4 Belgium Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.5 France Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.6 Italy Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.7 Denmark Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.8 Finland Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.9 Norway Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.10 Sweden Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.11 Poland Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.12 Russia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.3.13 Turkey Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.2 Japan Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.3 India Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.4 South Korea Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.8 Thailand Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.9 Singapore Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.11 Philippines Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.2 Colombia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.3 Chile Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.4 Argentina Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.6 Peru Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6.3 Oman Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6.4 Qatar Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.7.2 South Africa Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.7.3 Egypt Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.7.4 Algeria Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Short Bowel Syndrome Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Short Bowel Syndrome Drugs Consumption (2017-2022)
11 Global Short Bowel Syndrome Drugs Competitive Analysis
-
11.1 Nutrinia
-
11.1.1 Nutrinia Company Details
-
11.1.2 Nutrinia Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Nutrinia Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.1.4 Nutrinia Short Bowel Syndrome Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Sancilio Pharmaceuticals
-
11.2.1 Sancilio Pharmaceuticals Company Details
-
11.2.2 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.2.4 Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Naia Pharmaceuticals
-
11.3.1 Naia Pharmaceuticals Company Details
-
11.3.2 Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Naia Pharmaceuticals Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.3.4 Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Takeda
-
11.4.1 Takeda Company Details
-
11.4.2 Takeda Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Takeda Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.4.4 Takeda Short Bowel Syndrome Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Ardelyx
-
11.5.1 Ardelyx Company Details
-
11.5.2 Ardelyx Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Ardelyx Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.5.4 Ardelyx Short Bowel Syndrome Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Merck
-
11.6.1 Merck Company Details
-
11.6.2 Merck Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Merck Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.6.4 Merck Short Bowel Syndrome Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 OxThera
-
11.7.1 OxThera Company Details
-
11.7.2 OxThera Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 OxThera Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.7.4 OxThera Short Bowel Syndrome Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Zealand Pharma
-
11.8.1 Zealand Pharma Company Details
-
11.8.2 Zealand Pharma Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Zealand Pharma Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.8.4 Zealand Pharma Short Bowel Syndrome Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Emmaus Medical
-
11.9.1 Emmaus Medical Company Details
-
11.9.2 Emmaus Medical Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Emmaus Medical Short Bowel Syndrome Drugs Main Business and Markets Served
-
11.9.4 Emmaus Medical Short Bowel Syndrome Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
12 Global Short Bowel Syndrome Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Glucagon-Like Peptide-2 (GLP-2) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Short Bowel Syndrome Drugs Market Analysis and Outlook to 2028
-
13.1 Global Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Short Bowel Syndrome Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Short Bowel Syndrome Drugs
-
Figure of Short Bowel Syndrome Drugs Picture
-
Table Global Short Bowel Syndrome Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Short Bowel Syndrome Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Glucagon-Like Peptide-2 (GLP-2) Consumption and Growth Rate (2017-2022)
-
Figure Global Growth Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Glutamine Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Online Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Table North America Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure United States Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure Germany Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure China Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure Brazil Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Short Bowel Syndrome Drugs Consumption by Country (2017-2022)
-
Figure Australia Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Short Bowel Syndrome Drugs Consumption and Growth Rate (2017-2022)
-
Table Nutrinia Company Details
-
Table Nutrinia Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nutrinia Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Nutrinia Short Bowel Syndrome Drugs Product Portfolio
-
Table Sancilio Pharmaceuticals Company Details
-
Table Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Sancilio Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
-
Table Naia Pharmaceuticals Company Details
-
Table Naia Pharmaceuticals Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Naia Pharmaceuticals Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Naia Pharmaceuticals Short Bowel Syndrome Drugs Product Portfolio
-
Table Takeda Company Details
-
Table Takeda Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Takeda Short Bowel Syndrome Drugs Product Portfolio
-
Table Ardelyx Company Details
-
Table Ardelyx Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ardelyx Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Ardelyx Short Bowel Syndrome Drugs Product Portfolio
-
Table Merck Company Details
-
Table Merck Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Merck Short Bowel Syndrome Drugs Product Portfolio
-
Table OxThera Company Details
-
Table OxThera Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table OxThera Short Bowel Syndrome Drugs Product Portfolio
-
Table Zealand Pharma Company Details
-
Table Zealand Pharma Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Zealand Pharma Short Bowel Syndrome Drugs Product Portfolio
-
Table Emmaus Medical Company Details
-
Table Emmaus Medical Short Bowel Syndrome Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Emmaus Medical Short Bowel Syndrome Drugs Main Business and Markets Served
-
Table Emmaus Medical Short Bowel Syndrome Drugs Product Portfolio
-
Figure Global Glucagon-Like Peptide-2 (GLP-2) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Growth Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glutamine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Online Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Short Bowel Syndrome Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Short Bowel Syndrome Drugs Consumption Forecast and Growth Rate (2022-2028)
-
